Dr. Gunturu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Lahey hospital and medical center
41 mall road
Burlington, MA 01805Phone+1 781-744-8400Fax+1 781-744-5245- Is this information wrong?
Education & Training
- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2005 - 2008
- Rangaraya Medical College NTRClass of 2004
Certifications & Licensure
- NH State Medical License 2008 - Present
- CT State Medical License 2008 - 2024
- MA State Medical License 2012 - 2024
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2010-2013
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2010-2013
Clinical Trials
- S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer Start of enrollment: 2015 May 07
- Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma Start of enrollment: 2017 Oct 23
- Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy Start of enrollment: 2017 Apr 28
Publications & Presentations
PubMed
- 1 citationsSafety of sequential immune checkpoint inhibitors after prior immune therapy.Muhammad Awidi, Brendan Connell, Delaney Johnson, Isabel Craven, Rojer Ranjit, Brigitte Gil, Natalie Dal'Bo, Lewena Maher, Seanna Reilly Daves, Stephanie McDonald, Kri...> ;Journal of Cancer Research and Clinical Oncology. 2023 Jun 1
- 9 citationsImmune checkpoint inhibitors: immune-related adverse events, healthcare utilization, and costs among commercial and Medicare Advantage patients.Krishna S Gunturu, Timothy T Pham, Sonali Shambhu, Michael J Fisch, John J Barron, David Debono> ;Supportive Care in Cancer. 2022 May 1
- 17 citationsAdjuvant pembrolizumab versus interferon alfa-2b or ipilimumab in resected high-risk melanoma.Kenneth F. Grossmann, Megan Othus, Sapna Pradyuman Patel, Ahmad A. Tarhini, Vernon K. Sondak, Michael V. Knopp, Teresa M. Petrella, Thach-Giao Truong, Nikhil I. Khusha...> ;Cancer Discovery. 2021 Nov 11
- Join now to see all
Press Mentions
- Clinical Trials 101: What You Need to KnowJanuary 8th, 2019
Committees
- Member, SWOG Digital Engagement Committe 2017 - Present
- Member, SWOG Thoracic Committe 2016 - Present
- Member, SWOG Survivorship committe 2016 - Present
Research History
- IRB member2014 - Present
- Clinical Research2005 - Present
Professional Memberships
- Member
Other Languages
- Telugu
Hospital Affiliations
- Tufts Medical CenterBoston, Massachusetts
- Beverly HospitalBeverly, Massachusetts
- Lahey Hospital & Medical CenterBurlington, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: